Articles From: CCMP Capital Closes The Hillman Companies Acquisition to Fate Therapeutics Submits IND Application for the Clinical Development of PROHEMA(R) in Inherited Metabolic Disorders


2014/6/30
NEW YORK and CINCINNATI , June 30, 2014 /PRNewswire/ -- CCMP Capital Advisors, LLC ("CCMP") and The Hillman Companies, Inc. ("Hillman") today announced that they have completed the previously announced acquisition by affiliates of CCMP of a controlling interest in Hillman from Oak Hill Capital Partners ("Oak Hill Capital"). CCMP invested in partnership with Hillman's current management team, led by CEO Jim Waters .
Sign-up for CCMP Capital Closes The Hillman Companies Acquisition investment picks
HOUSTON, June 30, 2014 (GLOBE NEWSWIRE) -- LINN Energy, LLC (Nasdaq:LINE) and its wholly owned subsidiary, Linn Energy Finance Corp., announced today the closing of the offer to exchange any and all of its $1,800,000,000 outstanding principal amount of 6.250% Senior Notes due 2019 for an equal amount of new 6.250% Senior Notes due 2019.
Sign-up for LINN Energy Closes Exchange Offer for 6.250% Senior Notes Due 2019 investment picks
Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED ® technology and materials, today announced an expanded evaluation agreement with BOE Technology Group Co., Ltd.
Sign-up for BOE Technology Group Expands Evaluation Partnership with Universal Display Corporation investment picks
SUGAR LAND, Texas , June 30, 2014 /PRNewswire/ -- CVR Refining, LP (NYSE: CVRR) ("CVR Refining") today announced the closing of its public offering of 6,500,000 common units representing limited partner interests ("Common Units"). CVR Refining and CVR Refining Holdings, LLC ("CVR Refining Holdings") have granted the underwriters an option to purchase up to an aggregate additional 975,000 Common Units at a price of $26.07 per Common Unit.
Sign-up for CVR Refining Announces Closing Of Public Offering Of Common Units investment picks
NEW YORK, June 30, 2014 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Western District of Washington on behalf of investors who purchased Blucora, Inc. ("Blucora" or the "Company") (Nasdaq:BCOR) common stock between November 5, 2013 and February 20, 2014.
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Blucora, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- BCOR investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0955056001&sourceType=1 http://media3.marketwire.com/logos/20140428-GASFRAC%20.jpg CALGARY, ALBERTA --
Sign-up for GASFRAC Announces Resignation and Appointment of Directors investment picks
CONSHOHOCKEN, Pa.
Sign-up for Quaker Acquires Remaining Interest In Australian Affiliate investment picks
BROOMFIELD, Colo., June 30, 2014 (GLOBE NEWSWIRE) -- Noodles & Company , (Nasdaq:NDLS) serving classic noodle and pasta dishes from around the world, announced it's now serving its world of flavors under a new roof – yours.
Sign-up for Photo Release -- Noodles & Company Debuts Catering in Colorado investment picks
NEW YORK, June 30, 2014 (GLOBE NEWSWIRE) -- StoneCastle Financial Corp.
Sign-up for StoneCastle Financial Corp. Completes Deployment of Initial Capital and Secures Credit Facility investment picks
Joint Venture Companies to Provide Architectural, Engineering, and Environmental Services for the Tactical Training Theater Assessment and Planning Program CHARLOTTESVILLE, Va.
Sign-up for Cardno TEC-Leidos Joint Venture Awarded Contract By Naval Facilities Engineering Command Atlantic investment picks
2014/6/30
TECO Energy, Inc. (NYSE:TE) today announced that it plans to offer 15.5 million shares of its common stock pursuant to an effective shelf registration statement through underwriters led by Morgan Stanley, Citigroup and JP Morgan as joint bookrunning managers.
Sign-up for TECO Energy Announces Proposed Public Offering of Common Stock investment picks
Anworth Mortgage Asset Corporation (NYSE: ANH) announced that in accordance with the terms of Anworth’s 6.25% Series B Cumulative Convertible Preferred Stock, or Series B Preferred Stock, the Company announced that the conversion rate of the Series B Preferred Stock will increase from 4.0411 shares of Anworth’s common stock to 4.0919 shares of its common stock effective July 1, 2014.
Sign-up for Anworth Announced Increase to Series B Preferred Stock Conversion Rate investment picks
2014/6/30
ANN ARBOR, Mich.
Sign-up for Advanced Photonix, Inc. Reports Fiscal 2014 Revenues up 23% investment picks
2014/6/30
Scalable network of rapidly-deployable field engineers and technology workforce enhances robust portfolio of professional services readily available to Ingram Micro channel partners SANTA ANA, Calif.
Sign-up for Ingram Micro Expands Professional Services Offerings Through Rollouts Acquisition investment picks
JACKSONVILLE, Fla.
Sign-up for Fidelity National Financial, Inc. Announces Distribution of FNFV Tracking Stock investment picks
2014/6/30
WASHINGTON , June 30, 2014 /PRNewswire/ -- Fannie Mae's (OTC Bulletin Board: FNMA) May 2014 Monthly Summary is now available.
Sign-up for Fannie Mae Releases May 2014 Monthly Summary investment picks
2014/6/30
Mobile Mini, Inc. (Nasdaq GS:MINI) today announced it has completed the purchase of the assets and operations of two portable storage businesses with operations in Connecticut, Memphis, Tennessee and Dallas, Texas.
Sign-up for Mobile Mini Completes Acquisitions in Connecticut, Texas and Tennessee investment picks
2014/6/30
Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency Canada NewsWire Phase 3 Study Meets Primary Endpoint and Six Secondary Endpoints Across Multiple Disease-Related Abnormalities Conference Call and Webcast to be Held Today at 4:30 p.m. EDT LEXINGTON, Mass.
Sign-up for Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency investment picks
2014/6/30
Phase 3 Study Meets Primary Endpoint and Six Secondary Endpoints Across Multiple Disease-Related Abnormalities Conference Call and Webcast to be Held Today at 4:30 p.m. EDT LEXINGTON, Mass.
Sign-up for Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency investment picks
2014/6/30
http://media.marketwire.com/attachments/201306/161647_426957_safe.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1127822&ProfileId=051205&sourceType=1 ATHENS, GREECE --
Sign-up for Safe Bulkers, Inc. Announces the Closing of Its Public Offering of Series D Preferred Shares investment picks
FAIRMONT, W.Va. , June 30, 2014 /PRNewswire/ -- MVB Financial Corp., (OTCQB: MVBF) (the "Company"), the parent company of MVB Bank, Inc. (the "Bank"), MVB Mortgage and MVB Insurance, LLC, announced today that it has completed a series of private placements resulting in gross proceeds of approximately $52.8 million .
Sign-up for MVB Financial Raises $52.8 Million To Support Future Growth investment picks
2014/6/30
NAPERVILLE, Ill.
Sign-up for Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for July 2014 investment picks
Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report second quarter 2014 financial results on Wednesday, July 23, 2014, before the financial markets open.
Sign-up for Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014 investment picks
SAN DIEGO , June 30, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the company has been added to the Russell 2000® Index following the annual reconstitution of its U.S. and global equity indexes on June 27 , 2014.
Sign-up for Mirati Therapeutics Added to Russell 2000 Index investment picks
MIDLAND, Mich., June 30, 2014 (GLOBE NEWSWIRE) -- Chemical Financial Corporation (Nasdaq:CHFC) announced today the closing of the sale of 375,000 shares of its common stock pursuant to the underwriters' exercise of the over-allotment option, which the Company granted in connection with its previously announced underwritten public offering of 2,500,000 shares of its common stock.
Sign-up for Chemical Financial Corporation Announces Underwriters' Exercise of Over-Allotment Option investment picks
SAN DIEGO, June 30, 2014 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE) , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for the clinical development of PROHEMA in pediatric patients with inherited metabolic disorders undergoing hematopoietic stem cell transplantation (HSCT). Pending FDA review of the IND application, the Company plans to initiate a Phase 1b clinical trial in pediatric patients who have inherited metabolic disorders where enzyme replacement therapy is not a viable treatment option, including certain patients with central nervous system involvement.
Sign-up for Fate Therapeutics Submits IND Application for the Clinical Development of PROHEMA(R) in Inherited Metabolic Disorders investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: CCMP Capital Closes The Hillman Companies Acquisition to Fate Therapeutics Submits IND Application for the Clinical Development of PROHEMA(R) in Inherited Metabolic Disorders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices